This paper is in the following e-collection/theme issue:

Infoveillance, Infodemiology, Digital Disease Surveillance, Infodemic Management (1010) Cancer Epidemiology, Cancer Surveillance and Infodemiology (67) Infodemiology and Infoveillance (1269) Behavioural Surveillance for Public Health (204) Public (e)Health, Digital Epidemiology and Public Health Informatics (636)

Published on in Vol 9 (2023)

This is a member publication of Imperial College London (Jisc)

Association Between Purchase of Over-the-Counter Medications and Ovarian Cancer Diagnosis in the Cancer Loyalty Card Study (CLOCS): Observational Case-Control Study

Association Between Purchase of Over-the-Counter Medications and Ovarian Cancer Diagnosis in the Cancer Loyalty Card Study (CLOCS): Observational Case-Control Study

Association Between Purchase of Over-the-Counter Medications and Ovarian Cancer Diagnosis in the Cancer Loyalty Card Study (CLOCS): Observational Case-Control Study

Authors of this article:

Hannah R Brewer1 Author Orcid Image ;   Yasemin Hirst2 Author Orcid Image ;   Marc Chadeau-Hyam3 Author Orcid Image ;   Eric Johnson3 Author Orcid Image ;   Sudha Sundar4 Author Orcid Image ;   James M Flanagan1 Author Orcid Image
Article Authors Cited by (11) Tweetations (62) Metrics

Journals

  1. Torjesen I. Ovarian cancer: Loyalty card data could help identify cases sooner. BMJ 2023:p227 View
  2. Zhai K, Yousef M, Mohammed S, Al-Dewik N, Qoronfleh M. Optimizing Clinical Workflow Using Precision Medicine and Advanced Data Analytics. Processes 2023;11(3):939 View
  3. Brewer H, Chadeau-Hyam M, Johnson E, Sundar S, Flanagan J, Hirst Y. Cancer Loyalty Card Study (CLOCS): feasibility outcomes for an observational case–control study focusing on the patient interval in ovarian cancer. BMJ Open 2023;13(6):e066022 View
  4. Yan P, Li F, Nicholas S, Maitland E, Tan J, Chen C, Wang J. Impact of pension income on healthcare utilization of older adults in rural China. International Journal for Equity in Health 2023;22(1) View
  5. Dilley J, Gentry-Maharaj A, Ryan A, Burnell M, Manchanda R, Kalsi J, Singh N, Woolas R, Sharma A, Williamson K, Mould T, Fallowfield L, Campbell S, Skates S, McGuire A, Parmar M, Jacobs I, Menon U. Ovarian cancer symptoms in pre-clinical invasive epithelial ovarian cancer – An exploratory analysis nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Gynecologic Oncology 2023;179:123 View
  6. Stoffel S, Law J, Kerrison R, Brewer H, Flanagan J, Hirst Y. Testing Behavioral Messages to Increase Recruitment to Health Research When Embedded Within Social Media Campaigns on Twitter: Web-Based Experimental Study. JMIR Formative Research 2024;8:e48538 View
  7. Barcroft J, Yom-Tov E, Lampos V, Ellis L, Guzman D, Ponce-López V, Bourne T, Cox I, Saso S. Using online search activity for earlier detection of gynaecological malignancy. BMC Public Health 2024;24(1) View
  8. Bradley S, Jones D, Wood S, Rafiq M, Bradley C, Hamilton W. Diagnosing cancer in English community pharmacies. BMJ 2024:e077087 View
  9. Scott S, Thompson M. “Notification! You May Have Cancer.” Could Smartphones and Wearables Help Detect Cancer Early?. JMIR Cancer 2024;10:e52577 View
  10. Wilson G, Brewer H, Flanagan J, von Wagner C, Hirst Y, Cao C. How Do Patients Use Self-Care to Manage Nonspecific Symptoms Prior to a Cancer Diagnosis? A Rapid Review to Inform Future Interventions to Reduce Delays in Presentation to Primary Care. European Journal of Cancer Care 2024;2024:1 View
  11. Moss E, Taylor A, Andreou A, Ang C, Arora R, Attygalle A, Banerjee S, Bowen R, Buckley L, Burbos N, Coleridge S, Edmondson R, El-Bahrawy M, Fotopoulou C, Frost J, Ganesan R, George A, Hanna L, Kaur B, Manchanda R, Maxwell H, Michael A, Miles T, Newton C, Nicum S, Ratnavelu N, Ryan N, Sundar S, Vroobel K, Walther A, Wong J, Morrison J. British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024. European Journal of Obstetrics & Gynecology and Reproductive Biology 2024 View